11 October 2017. Piramal Pharma Solutions (PPS) is set to invest $55m across its production sites in North America and Asia in order to expand its active pharmaceutical ingredients (API) manufacturing capabilities and capacities.



At industryabout.com:

Piramal World Facilities


You can post comments after registration

This site uses only session 3rd party cookies.

If you dont change browser settings you agree with it.

I understand